Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 12.69% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
ClearPoint Neuro
CLPT
$470M
| $90.3K | ﹤0.01% |
10,662
-10
| -0.1% | -$95 |
|
3952
Offerpad Solutions
OPAD
$21.8M
| $89.9K | ﹤0.01% |
1,302
| – | – |
|
3953
Alpha Teknova
TKNO
$396M
| $89.8K | ﹤0.01% |
15,914
-35
| -0.2% | -$155 |
|
3954
Summit Therapeutics
SMMT
$11.2B
| $89.7K | ﹤0.01% |
+21,111
| New | +$38.4K |
|
|
SHCO
3955
DELISTED
Soho House & Co
SHCO
| $89.3K | ﹤0.01% |
23,866
-2,958,027
| -99% | -$12.2M |
|
|
BRDS
3956
DELISTED
Bird Global, Inc.
BRDS
| $89.2K | ﹤0.01% |
19,793
+1,816
| +10% | +$13.3K |
|
3957
Phunware
PHUN
$43.4M
| $89K | ﹤0.01% |
2,301
+1,396
| +154% | +$75.9K |
|
|
GPUS
3958
Hyperscale Data Inc
GPUS
$52.2M
| $88K | ﹤0.01% |
5
+3
| +150% | +$68.9K |
|
|
SAND
3959
DELISTED
Sandstorm Gold
SAND
| $87.9K | ﹤0.01% |
16,703
+497
| +3% | +$2.54K |
|
3960
First Majestic Silver
AG
$9.26B
| $87.7K | ﹤0.01% |
+10,511
| New | +$91.8K |
|
3961
Flotek Industries
FTK
$1.25B
| $87.6K | ﹤0.01% |
13,030
-55
| -0.4% | -$383 |
|
|
TTOO
3962
DELISTED
T2 Biosystems, Inc
TTOO
| $85.6K | ﹤0.01% |
603
+495
| +458% | +$102K |
|
3963
Urban One Class A
UONE
$23.5M
| $84.5K | ﹤0.01% |
1,857
-130
| -7% | -$7K |
|
3964
GT Biopharma
GTBP
$10.7M
| $84.4K | ﹤0.01% |
3,175
| – | – |
|
3965
Heartbeam
BEAT
$32.7M
| $84.3K | ﹤0.01% |
17,284
+4,833
| +39% | +$20.9K |
|
|
CS
3966
DELISTED
Credit Suisse Group
CS
| $84.1K | ﹤0.01% |
27,674
-22,088
| -44% | -$85.9K |
|
|
IVAC
3967
DELISTED
Intevac Inc
IVAC
| $83.9K | ﹤0.01% |
12,962
| – | – |
|
3968
Genasys
GNSS
$77.9M
| $83.1K | ﹤0.01% |
22,469
-34,182
| -60% | -$98.9K |
|
3969
Lineage Cell Therapeutics
LCTX
$268M
| $82.9K | ﹤0.01% |
70,828
+1
| +0% | +$1 |
|
3970
Matinas BioPharma
MTNB
$1.49M
| $82.8K | ﹤0.01% |
3,313
-12
| -0.4% | -$399 |
|
3971
Cytosorbents Corp
CTSO
$22.8M
| $82.5K | ﹤0.01% |
53,237
-236
| -0.4% | -$350 |
|
|
AVYA
3972
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $82.2K | ﹤0.01% |
419,532
-130,101
| -24% | -$145K |
|
3973
Vor Biopharma
VOR
$1.38B
| $81.4K | ﹤0.01% |
+612
| New | +$60.6K |
|
|
LPTV
3974
DELISTED
Loop Media, Inc.
LPTV
| $81.4K | ﹤0.01% |
+12,293
| New | +$57.9K |
|
|
ICD
3975
DELISTED
Independence Contract Drilling, Inc.
ICD
| $81K | ﹤0.01% |
24,772
-193
| -0.8% | -$674 |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.